Contraception is deliberate use of artificial methods or other
techniques to prevent pregnancy as a consequence of sexual
intercourse. Contraceptive devices are intended to prevent
conception. These devices also help to prevent the spread of sexually
transmitted infections. Various awareness initiatives taken by market
players is a major factor propelling the global contraceptive devices
market. Bayer HealthCare, a major player in the contraceptives
market, in collaboration with 11 NGOs, organizes the World
Contraception Day every year on September 26 to spread awareness
about contraceptive methods, enabling young people to take the right
decision about their reproductive health.
The global contraceptive devices market is expected to grow
substantially due to factors such as high incidence rate of
unintended pregnancies, unmet contraceptive needs, rise in awareness
initiatives by governments and NGOs, and implementation of the
Affordable Care Act. A high percentage of population belonging to the
sexually active age group in Asia (India and China) coupled with
increase in disposable incomes of consumers belonging to such
economies is likely to offer significant opportunities in the
contraceptive devices market. However, side effects associated with
the use of contraceptive devices inducing people to opt for natural
and permanent contraceptive methods, and rise in prevalence of
infertility among women and aging population hamper the growth of the
global contraceptive devices market
Based on type, the global contraceptive devices market can be
segmented into male contraceptive devices and female contraceptive
devices. Male contraceptive devices comprise male condoms. Female
contraceptives include female condoms, contraceptive vaginal rings,
contraceptive diaphragms, contraceptive sponges, sub-dermal
contraceptive implants, intrauterine devices, and non-surgical
permanent contraceptive devices. Male condoms dominate the male
contraceptive devices segment due to almost universal adoption
facilitated by ease of use and lowest prices. Non-surgical permanent
contraceptive devices is projected to be the fastest growing
sub-segment of the female contraceptives segment. Growing popularity
among women who prefer to obtain permanent contraception without
painful surgeries is the major factor propelling the non-surgical
permanent contraceptive devices sub-segment. Based on end-user, the
global contraceptive devices market can be divided into hospitals,
clinics, ambulatory surgical centers, and home care.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35921
Geographically, the global contraceptive devices market can be
segmented into North America, Europe, Asia Pacific, and Rest of the
World. North America dominates the global market due to high
incidence rate of unplanned pregnancies, implementation of the
Affordable Care Act in the U.S., and high usage of contraceptive
devices in this region. Favorable reimbursement policies for
contraceptives by large insurance firms for all federal employees
(U.S.) and their dependents has contributed significantly to the
growth of the contraceptive devices market in North America. The
contraceptive devices market in Asia Pacific is expected to witness
the fastest growth during the forecast period. Strong economic growth
in India and China, high population, rise in disposable income,
increase in awareness about contraceptives and its advantages for
preventing pregnancy and sexually transmitted infections are expected
to accelerate the growth of the market in the region during the
forecast period.
Key players operating in the global contraceptive devices market
include Bayer HealthCare AG, Teva Pharmaceutical Industries Limited,
Medisafe Distribution, Inc., Actavis, Inc., Medicines360, Pace
Pharmaceuticals Inc., Cooper Surgical, Inc., Mayer Laboratories,
Inc., Church & Dwight, Co., Inc., Merck & Co., Inc., Reckitt
Benckiser plc, and Pfizer, Inc. These players focus on creating
various awareness programs and providing contraceptives at cost
effective prices to increase market share and sustain in the highly
competitive market.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=35921<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment